Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden
· Delayed Price · Currency is SEK 0.0798
+0.0054 (7.26%)
Apr 29, 2026, 9:05 AM CET
Simris Group AB (PUBL) Revenue
In the year 2025, Simris Group AB (PUBL) had annual revenue of 1.62M SEK, down -44.12%. Simris Group AB (PUBL) had revenue of 285.00K in the quarter ending December 31, 2025, a decrease of -70.65%.
Revenue
1.62M
Revenue Growth
-44.12%
P/S Ratio
66.86
Revenue / Employee
323.00K
Employees
5
Market Cap
107.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.62M | -1.28M | -44.12% |
| Dec 31, 2024 | 2.89M | -1.46M | -33.62% |
| Dec 31, 2023 | 4.35M | 274.00K | 6.72% |
| Dec 31, 2022 | 4.08M | -2.29M | -35.92% |
| Dec 31, 2021 | 6.37M | 4.08M | 178.77% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scandinavian ChemoTech AB | 12.29M |
| Magle Chemoswed Holding AB | 287.55M |
| IRLAB Therapeutics AB | 57.46M |
| Biovica International AB | 10.93M |
| NextCell Pharma AB | 9.83M |
| AcouSort AB | 10.43M |
| OncoZenge AB | 2.78M |
| Spago Nanomedical AB | 4.82M |